Ivan Osokine, PhD, MD

Title(s)Postdoctoral Scholar, Laboratory Medicine
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, Los AngelesMD2016David Geffen School of Medicine
    University of California, Los AngelesPhD2014Microbiology, Immunology, and Molecular Genetics

    Collapse Overview 
    Collapse Overview
    I am a postdoctoral scholar in the lab of Adrian Erlebacher. I study how the interaction between maternal and fetal tissue promotes a tolerogenic immune state that permits the fetus to develop and avoid rejection by the maternal immune system.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Snell LM, MacLeod BL, Law JC, Osokine I, Elsaesser HJ, Hezaveh K, Dickson RJ, Gavin MA, Guidos CJ, McGaha TL, Brooks DG. CD8+ T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory-like Cells for Sustained Immunity. Immunity. 2018 10 16; 49(4):678-694.e5. PMID: 30314757.
      View in: PubMed
    2. Nancy P, Siewiera J, Rizzuto G, Tagliani E, Osokine I, Manandhar P, Dolgalev I, Clementi C, Tsirigos A, Erlebacher A. H3K27me3 dynamics dictate evolving uterine states in pregnancy and parturition. J Clin Invest. 2018 01 02; 128(1):233-247. PMID: 29202469.
      View in: PubMed
    3. Osokine I, Erlebacher A. Inflammation and Autism: From Maternal Gut to Fetal Brain. Trends Mol Med. 2017 12; 23(12):1070-1071. PMID: 29122491.
      View in: PubMed
    4. Snell LM, Osokine I, Yamada DH, De la Fuente JR, Elsaesser HJ, Brooks DG. Overcoming CD4 Th1 Cell Fate Restrictions to Sustain Antiviral CD8 T Cells and Control Persistent Virus Infection. Cell Rep. 2016 09 20; 16(12):3286-3296. PMID: 27653690.
      View in: PubMed
    5. Osokine I, Snell LM, Cunningham CR, Yamada DH, Wilson EB, Elsaesser HJ, de la Torre JC, Brooks D. Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection. Proc Natl Acad Sci U S A. 2014 May 20; 111(20):7409-14. PMID: 24799699.
      View in: PubMed
    6. Osokine I, Hsu R, Loeb GB, McManus MT. Unintentional miRNA ablation is a risk factor in gene knockout studies: a short report. PLoS Genet. 2008 Feb; 4(2):e34. PMID: 18282110.
      View in: PubMed